advertisement

---

Molecular pharmaceutics 8

Showing records 1 to 8 | Display all abstracts in Molecular pharmaceutics

98868 Imaging Methods for the Assessment of a Complex Hydrogel as an Ocular Drug Delivery System for Glaucoma Treatment: Opportunities and Challenges in Preclinical Evaluation
Das S
Molecular pharmaceutics 2022; 19: 733-748

---

98366 In Situ Gelling Electrospun Ocular Films Sustain the Intraocular Pressure-Lowering Effect of Timolol Maleate: In Vitro, Ex Vivo, and Pharmacodynamic Assessment
Andreadis II
Molecular pharmaceutics 2022; 19: 274-286

---

98868 Imaging Methods for the Assessment of a Complex Hydrogel as an Ocular Drug Delivery System for Glaucoma Treatment: Opportunities and Challenges in Preclinical Evaluation
Saha D
Molecular pharmaceutics 2022; 19: 733-748

---

98366 In Situ Gelling Electrospun Ocular Films Sustain the Intraocular Pressure-Lowering Effect of Timolol Maleate: In Vitro, Ex Vivo, and Pharmacodynamic Assessment
Karavasili C
Molecular pharmaceutics 2022; 19: 274-286

---

98868 Imaging Methods for the Assessment of a Complex Hydrogel as an Ocular Drug Delivery System for Glaucoma Treatment: Opportunities and Challenges in Preclinical Evaluation
Majumdar S
Molecular pharmaceutics 2022; 19: 733-748

---

98366 In Situ Gelling Electrospun Ocular Films Sustain the Intraocular Pressure-Lowering Effect of Timolol Maleate: In Vitro, Ex Vivo, and Pharmacodynamic Assessment
Thomas A; Komnenou A
Molecular pharmaceutics 2022; 19: 274-286

---

98868 Imaging Methods for the Assessment of a Complex Hydrogel as an Ocular Drug Delivery System for Glaucoma Treatment: Opportunities and Challenges in Preclinical Evaluation
Giri L
Molecular pharmaceutics 2022; 19: 733-748

---

98366 In Situ Gelling Electrospun Ocular Films Sustain the Intraocular Pressure-Lowering Effect of Timolol Maleate: In Vitro, Ex Vivo, and Pharmacodynamic Assessment
Tzimtzimis M; Tzetzis D; Andreadis D; Bouropoulos N; Fatouros DG
Molecular pharmaceutics 2022; 19: 274-286

---